Use of dopamine receptor antagonists in palliative tumour...

Details Use of dopamine receptor antagonists in palliative tumour... Use of dopamine receptor antagonists in palliative tumour...

A - Human Necessities

61

K

A61K 31/675 (2006.01) A61K 31/445 (2006.01) A61K 31/454 (2006.01) A61P 1/14 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2223469

The side effect of decrease in body weight caused by the alkylphosphocholines such as miltefosine can be antagonized by certain antagonists such as domperidone and pimozide. It is important here that the combination of alkylphosphocholine plus antidote does not have any effect on the antitumour action of the alkylphosphocholines. The combination also caused no new side effects in the animals.

Affiliated with

Also associated with

Rating

Use of dopamine receptor antagonists in palliative tumour... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of dopamine receptor antagonists in palliative tumour..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of dopamine receptor antagonists in palliative tumour... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2008221